Key Financial Figures (₹ in lakhs)
Financial Performance Comparison:
| Metric | FY 2025-26 (31.03.2026) | FY 2024-25 (31.03.2025) | Change |
| Operating Income | 2585.84 | 2265.03 | +14.17% |
| Other Income | 32.93 | 41.40 | -20.46% |
| Profit Before Tax | 40.00 | 55.59 | -28.04% |
| Tax Expense | 0.92 | 4.97 | -81.49% |
| Profit After Tax | 39.07 | 50.61 | -22.80% |
| EPS (Basic & Diluted) | 0.94 | 1.60 | -41.25% |
Balance Sheet Highlights:
| Item | 31.03.2026 | 31.03.2025 |
| Total Assets | 1757.85 | 1477.99 |
| Equity Share Capital | 415.36 | 415.36 |
| Other Equity | 636.20 | 597.75 |
| Total Equity | 1051.56 | 1013.11 |
| Current Assets | 640.64 | 458.93 |
| Current Liabilities | 550.44 | 307.22 |
| Net Worth | 1051.56 | 1013.11 |
Operational Highlights
- Company operates in healthcare sector providing multi-specialty hospital services including Cardiology, Gastroenterology, Neurology, Urology, Nephrology, and diagnostic care
- Revenue growth driven by increased hospital operations
- Profit decline attributed to increased operating costs and depreciation (₹68.98 lakh vs ₹56.46 lakh previous year)
- Company remains debt-free with no long-term borrowings
- Employee strength: 118 employees as of March 2026
AGM Details
- 33rd Annual General Meeting to be held on Tuesday, September 29, 2026 at 3:00 PM
- Meeting will be conducted through Video Conferencing/Audio Visual Means
- Cut-off date for determining voting eligibility: September 22, 2026
- Remote e-voting period: September 26, 2026 (9:00 AM) to September 28, 2026 (5:00 PM)
- Register of Members and Share Transfer Books to remain closed from September 23-29, 2026
Business to be Transacted
Ordinary Business:
1. Adoption of Audited Standalone Financial Statements for FY ended March 31, 2026
2. Re-appointment of Mr. Tulsi Prasad Sharma (DIN: 09619078) as Director retiring by rotation
3. Re-appointment of Mrs. Rowena Sharma (DIN: 02477356) as Director retiring by rotation
Dividend Declaration
- Board has decided not to recommend any dividend for FY 2025-26 due to insufficient profits and anticipated capital expenses
- No funds were transferred to Investor Education and Protection Fund (IEPF) during the year
Corporate Governance
- Paid-up Share Capital: ₹415.36 lakh
- Net Worth: ₹1051.56 lakh
- Regulation 27(2) of SEBI LODR not applicable due to size parameters
- Company states it has made efforts to comply with applicable corporate governance requirements
Board Composition and Meetings
- Board consists of 9 Directors including 3 Independent Directors
- 12 Board meetings held during FY 2025-26
- All directors attended all board meetings
- Key Managerial Personnel: Mrs. Shalini Sharma (Managing Director), Mr. Bikram Singh (CFO), Mrs. Ritika Bhandari (Company Secretary)
Director Details for Re-appointment
Mr. Tulsi Prasad Sharma
- DIN: 09619078
- Date of Appointment: May 5, 2022
- Age: 57 years
- Nationality: Indian
- Qualification: Several years experience in administrative support
- Shareholding in Dhanvantri Jeevan Rekha Ltd. and other group companies
Mrs. Rowena Sharma
- DIN: 02477356
- Date of Appointment: September 30, 2021
- Age: 71 years
- Nationality: Indian
- Qualification: B.Com
- Extensive shareholding across multiple group companies
Statutory Auditors
- M/s Anuj Goyal & Co., Chartered Accountants (FRN: 004881C)
- Appointed until conclusion of 34th AGM
- Remuneration: Mutually agreed between Board and Auditors
- Issued unqualified audit report
Secretarial Auditors
- M/s Sumit Bist & Associates, Practicing Company Secretaries (FRN: 22707)
- Issued secretarial audit report with one observation regarding promoter share dematerialization (only 70% dematerialized as of March 31, 2026)
Internal Financial Controls
- Company maintains adequate internal financial controls system
- Internal controls were operating effectively during the year
- No reportable material weaknesses identified
Related Party Transactions
- Transactions with related parties disclosed in Note 23 to financial statements
- Includes sitting fees to directors totaling ₹40.95 lakh
- Consultancy charges paid to Dr. Anil Elhence: ₹93.67 lakh
- Professional charges to Kashyap & Co.: ₹0.65 lakh
- Company states no materially significant related party transactions with potential conflict of interest
Risk Management
- Company has designed risk management policy and framework
- No Risk Management Committee constituted as not required under Regulation 21 of SEBI LODR
- No significant material orders passed by regulators/courts impacting going concern status
Corporate Social Responsibility
- Provisions of Section 135 of Companies Act, 2013 not applicable to the company
Key Ratios and Significant Changes (>25% variance)
1. Return on Equity Ratio: Decreased from 6.71% to 3.72% (-44.46%) due to profit decline
2. Inventory Turnover Ratio: Increased from 149.39 to 326.15 times (+118.33%) due to inventory drawdown
3. Net Capital Turnover Ratio: Increased from 14.93 to 28.67 times (+92.01%) due to working capital contraction
4. Net Profit Ratio: Decreased from 2.90% to 1.49% (-48.76%) due to margin compression
5. Return on Capital Employed: Decreased from 5.80% to 3.97% (-31.59%) due to lower EBIT
Other Disclosures
- No fraud reported during the year
- No sexual harassment complaints filed under POSH Act
- No deposits accepted from public under Sections 73-76 of Companies Act
- Company securities listed on Bombay Stock Exchange
- Share Transfer Agent: Beetal Financial & Computer Services Pvt Ltd
Auditor's Reports
Statutory Auditor's Report (M/s Anuj Goyal & Co.)
- Unqualified opinion on financial statements
- No observations, qualifications or adverse remarks
- Internal financial controls adequate and operating effectively
Secretarial Audit Report (M/s Sumit Bist & Associates)
- Clean report except for one observation regarding promoter share dematerialization (70% dematerialized vs 100% requirement)
- Company complied with applicable statutory provisions